John Redman
Family Medicine · Anahuac, TXNPI 1356522759
Payments from drug & device makers
Across 75 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$273
- Bayer$204
- AstraZeneca$178
- Lilly USA, LLC$115
- Axsome Therapeutics, Inc.$81
- Exact Sciences$80
- plus $457 from 16 others
What the payments were for
- Food & beverage$1,388100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 16 | $273 |
| Bayer | 8 | $204 |
| AstraZeneca | 12 | $178 |
| Lilly USA, LLC | 6 | $115 |
| Axsome Therapeutics, Inc. | 3 | $81 |
| Exact Sciences | 3 | $80 |
| Ironshore Pharmaceuticals Inc. | 3 | $53 |
| Abbott | 2 | $46 |
| Organon | 3 | $45 |
| Pfizer | 3 | $42 |
| Amarin Pharma, Inc. | 2 | $38 |
| Dexcom, Inc. | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $28 |
| Johnson & Johnson | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Merck | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| GSK | 1 | $13 |
| Radius Health, Inc. | 1 | $13 |
| Corium, LLC | 1 | $12 |
How this compares
$1,388 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 194 | $197,389 |
| FarxigaDapagliflozin Propanediol | 177 | $124,487 |
| JardianceEmpagliflozin | 126 | $112,391 |
| TrulicityDulaglutide | 91 | $97,545 |
| EliquisApixaban | 98 | $63,523 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 87 | $58,649 |
| JanuviaSitagliptin Phosphate | 27 | $31,839 |
| MounjaroTirzepatide | 25 | $28,981 |
| Breo ElliptaFluticasone/Vilanterol | 59 | $27,019 |
| RybelsusSemaglutide | 25 | $24,257 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 35 | $23,785 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 30 | $18,451 |
| XareltoRivaroxaban | 27 | $18,356 |
| EntrestoSacubitril/Valsartan | 26 | $18,172 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 14 | $17,638 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $273 | $221,646219 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $178 | $160,375230 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta, Combivent Respimat, Spiriva Respimat | $15 | $154,634201 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $115 | $126,525116 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $13 | $99,049171 claims |
| PfizerEliquis | $42 | $63,52398 claims |
| MerckJanuvia, Janumet Xr | $15 | $49,47741 claims |
| Johnson & JohnsonXarelto | $17 | $18,35627 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Anahuac
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.